Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
1994 | Cutaneous Manifestations of Epstein-Barr Virus-Associated T-Cell Lymphoma | Cheng, Ann-Lii; Su, I. J.; Tsai, T. F.; 鄭安理 | Journal of American Academy Dermatology | | | |
1991 | Cutaneous Manifestations of Peripheral T-Cell Lymphoma | Su, I. J.; Hsieh, H. C.; Cheng, Ann-Lii; 鄭安理 | Journal of American Academy Dermatology | | | |
1990 | Cutaneous Manifestations of Postthymic T Cell Malignancies:Description of Five Clinicopathologic Subtypes | 蘇益仁; 吳英俊; 陳耀昌; Hsieh, Hong-Chung; 鄭安理; 王秋華; Kadin Marshall E; Su, Ih-Jen; Wu, Ying-Chin; Chen, Yao-Chang; Cheng, Ann-Lii; Wang, Chiu-Hwa | Journal of the American Academy of Dermatology | | | |
2014 | Development of GADD45 beta (growth arrest DNA damage-inducible gene 45 beta) agonists for the treatment of hepatocellular carcinoma (HCC) | Hsu, Chiun; Ou, Da-Liang; Chen, Kuen-Feng; Lin, Zhong-Zhe; Cheng, Ann-Lii; Shiau, Chung-Wai; 鄭安理 | Cancer Res. | 0 | 0 | |
1991 | Different Tumor Biology between Peripheral T-Cell Lymphoma and Diffuse B-Cell Lymphoma-Implication on Treatment Planning | Cheng, Ann-Lii; Su, I. J.; 鄭安理 | Program and Abstract, Fourth International Conference on Malignant Lymphoma | | | |
1990 | Differential Responses to Chemotherapy in Peripheral T-Cell Lymphoma and Diffuse B-Cell Lymphoma-Features Useful in Treatment Planning | Cheng, Ann-Lii; Wang, C. H.; Chen, Yee-Chun; 鄭安理 | Journal of Chinese Oncology Society, ROC | | | |
1994 | Differential Susceptibility to Cytotoxic and Biologic Agents of Lymphoma Cell Lines | Cheng, Ann-Lii; Su, I. J.; 鄭安理 | Annual Meeting of the American Association for Cancer Research. Proceedings | | | |
1993 | Disruption of Cellular Energy Balance by Suramin in Intact Human Prostatic Carcinoma Cells, a Likely Antiproliferative Mechanism | Rago, R.; Mitchen, J.; Cheng, Ann-Lii; 鄭安理 | Cancer Research | | | |
2009 | Effect of Macroscopic Vascular Invasion (Mvi), Extrahepatic Spread (Ehs), and Ecog Performance Status (Ecog Ps) on Outcome in Patients with Advanced Hepatocellular Carcinoma (Hcc) Treated with Sorafenib: Analysis of Two Phase Iii, Randomized, Double-Blind | CHENG, ANN-LII; TSAO, CHAO-JUNG; 鄭安理 | JOURNAL OF CLINICAL ONCOLOGY | | | |
2015 | Efficacy and safety of nintedanib (N) versus sorafenib (S) in Caucasian and Asian patients with advanced hepatocellular carcinoma (HCC): Pooled analysis of two randomized phase II trials. | Meyer, Tim; Palmer, Daniel H.; Chao, Yee; Choi, Caren; Deptala, Andrzej; Fartoux, Laetitia; Feng, Yin-Hsun; Graham, Janet Shirley; Hocke, Julia; Kim, Tae-You; Lin, Deng-Yn; Ma, Yuk Ting; Peck-Radosavljevic, Markus; Ross, Paul J.; Ryoo, Baek-Yeol; Wenz, Arne; Yen, Chia-Jui; Loembe, Arsene-Bienvenu; Cheng, Ann-Lii | J. Clin. Oncol. | | | |
2015 | Efficacy and safety of nintedanib (N) versus sorafenib (S) in Caucasian and Asian patients with advanced hepatocellular carcinoma (HCC): Pooled analysis of two randomized phase II trials. | Meyer, Tim; Palmer, Daniel H.; Chao, Yee; Choi, Caren; Deptala, Andrzej; Fartoux, Laetitia; Feng, Yin-Hsun; Graham, Janet Shirley; Hocke, Julia; Kim, Tae-You; Lin, Deng-Yn; Ma, Yuk Ting; Peck-Radosavljevic, Markus; Ross, Paul J.; Ryoo, Baek-Yeol; Wenz, Arne; Yen, Chia-Jui; Loembe, Arsene-Bienvenu; Cheng, Ann-Lii; 鄭安理 | J. Clin. Oncol. | | | |
2009 | Efficacy and Safety of Sorafenib in Patients with Advanced Hepatocellular Carcinoma (Hcc): Asia-Pacific (Ap) Trial Subgroup Analyses by Baseline Transaminase (Alt/Ast)/(Alpha)-Fetoprotein (Afp) Levels | TSAO, CHAO-JUNG; CHENG, ANN-LII; 鄭安理 | JOURNAL OF CLINICAL ONCOLOGY | | | |
2009 | Efficacy and Safety of Sorafenib in Patients with Advanced Hepatocellular Carcinoma (Hcc): Collective Results from the Phase Iii Sorafenib Hcc Assessment Randomized Protocol (Sharp) and Asia-Pacific (Ap) Trials | CHENG, ANN-LII; 鄭安理 | EJC SUPPLEMENTS | | | |
2021 | An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma | Shen, Ying-Chun; Lee, Pei-Chang; Kuo, Yu-Lun; WEI-KAI WU ; Chen, Chieh-Chang; Lei, Chengh-Hau; Yeh, Ching-Ping; CHIUN HSU; CHIH-HUNG HSU; Lin, Zhong-Zhe; Shao, Yu-Yun; Lu, Li-Chun; Liu, Tsung-Hao; Chen, Chien-Hung; Wu, Ming-Shiang; Huang, Yi-Hsiang; Cheng, Ann-Lii | Journal of hepatocellular carcinoma | | 14 | |
1991 | Expression of Growth-Related Genes and Drug-Resistance Genes in HTLV-I-Positive and HTLV-I-Negative Post-Thymic T-Cell Malignancies | Su, I. J.; Chang, I. C.; Cheng, Ann-Lii; 鄭安理 | Annals Oncology | | | |
1993 | Expression of P-Glycoprotein and Glutathione-S-Transferase in Recurrent Lymphoma:The Possible Role of Epstein-Barr Virus, Immunophenotypes, and Other Predisposing Factors | Cheng, Ann-Lii; Chen, Yee-Chun; 鄭安理 | Journal of Clinical Oncology | | | |
1997 | Factors Associated with the Therapeutic Efficacy of Retinoic Acids on Malignant Lymphomas | CHENG, ANN-LII; CHUANG, SHUANG-EN; LIN, CHIEN-HSING; LUO, YOU-JEN; PU, YEONG-SHIAU; SU, IH-JEN; 鄭安理 | JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION | | | |
2007 | Gemcitabine Is Preferentially Chemosensitive in Cyclin D1 or Cyclin E over-Expressing Human Gastric Cancer Cells | SHEN, YING-CHUN; CHENG, ANN-LII; 鄭安理 | ANNALS OF ONCOLOGY | | | |
2013 | Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: a meta-analysis and meta-regression (vol 15, pg 265, 2012) | Hsu, Chiun; Shen, Ying-Chun; Cheng, Chia-Chi; Cheng, Ann-Lii; Hu, Fu-Chang; Yeh, Kun-Huei; 鄭安理 | Gastric Cancer | | | |
2013 | Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: a meta-analysis and meta-regression (vol 15, pg 265, 2012) | Hsu, Chiun; Shen, Ying-Chun; Cheng, Chia-Chi; Cheng, Ann-Lii; Hu, Fu-Chang; Yeh, Kun-Huei | Gastric Cancer | | | |